FR2853910B1 - Genes du psoriasis - Google Patents

Genes du psoriasis

Info

Publication number
FR2853910B1
FR2853910B1 FR0304773A FR0304773A FR2853910B1 FR 2853910 B1 FR2853910 B1 FR 2853910B1 FR 0304773 A FR0304773 A FR 0304773A FR 0304773 A FR0304773 A FR 0304773A FR 2853910 B1 FR2853910 B1 FR 2853910B1
Authority
FR
France
Prior art keywords
psoriasis
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0304773A
Other languages
English (en)
Other versions
FR2853910A1 (fr
Inventor
Valerie Trinquet
Patricia Rossio
Paul Fogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to FR0304773A priority Critical patent/FR2853910B1/fr
Priority to EP04742515A priority patent/EP1618213A2/fr
Priority to PCT/FR2004/000934 priority patent/WO2004094661A2/fr
Priority to CA002522120A priority patent/CA2522120A1/fr
Publication of FR2853910A1 publication Critical patent/FR2853910A1/fr
Priority to US11/249,305 priority patent/US20060115836A1/en
Application granted granted Critical
Publication of FR2853910B1 publication Critical patent/FR2853910B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0304773A 2003-04-16 2003-04-16 Genes du psoriasis Expired - Fee Related FR2853910B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0304773A FR2853910B1 (fr) 2003-04-16 2003-04-16 Genes du psoriasis
EP04742515A EP1618213A2 (fr) 2003-04-16 2004-04-15 Genes fancc, dad1, grim19 et hadhii marqueurs du psoriasis
PCT/FR2004/000934 WO2004094661A2 (fr) 2003-04-16 2004-04-15 Genes fancc, dad1, grim19 et hadhii marquers du psoriasis
CA002522120A CA2522120A1 (fr) 2003-04-16 2004-04-15 Genes fancc, dad1, grim19 et hadhii du psoriasis
US11/249,305 US20060115836A1 (en) 2003-04-16 2005-10-14 Utilization of FANCC, DAD1, GRIM19 and HADHII genes for the ultimate treatment of psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0304773A FR2853910B1 (fr) 2003-04-16 2003-04-16 Genes du psoriasis

Publications (2)

Publication Number Publication Date
FR2853910A1 FR2853910A1 (fr) 2004-10-22
FR2853910B1 true FR2853910B1 (fr) 2007-08-24

Family

ID=33041917

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0304773A Expired - Fee Related FR2853910B1 (fr) 2003-04-16 2003-04-16 Genes du psoriasis

Country Status (5)

Country Link
US (1) US20060115836A1 (fr)
EP (1) EP1618213A2 (fr)
CA (1) CA2522120A1 (fr)
FR (1) FR2853910B1 (fr)
WO (1) WO2004094661A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2983873B1 (fr) * 2011-12-13 2016-12-30 Oreal Marqueurs indicatifs de l'etat d'un cuir chevelu et utilisations.
KR101724169B1 (ko) * 2012-09-05 2017-04-06 가톨릭대학교 산학협력단 Ｇｒｉｍ19를 유효성분으로 함유하는 비만 또는 지질 관련 대사성 질환의 예방 또는 치료용 조성물
CN105861709B (zh) * 2016-05-19 2019-10-18 山东大学齐鲁医院 利用颗粒细胞grim-19相对表达量来评价卵母细胞发育潜能的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993022435A1 (fr) * 1992-04-29 1993-11-11 Hospital For Sick Children Gene de la maladie de fanconi pour le groupe c de complementation
WO1998051792A1 (fr) * 1997-05-15 1998-11-19 Brigham & Women's Hospital, Inc. Molecules fac et leurs utilisations
WO2000009754A2 (fr) * 1998-08-14 2000-02-24 Johnson & Johnson Consumer Companies, Inc. COMPOSITIONS ASSOCIEES A LA STEAROYL-CoA DESATURASE HUMAINE ET PROCEDES DE TRAITEMENT D'AFFECTIONS CUTANEES
GB9906993D0 (en) * 1999-03-26 1999-05-19 Univ Leicester Psoriasis

Also Published As

Publication number Publication date
WO2004094661A2 (fr) 2004-11-04
US20060115836A1 (en) 2006-06-01
EP1618213A2 (fr) 2006-01-25
CA2522120A1 (fr) 2004-11-04
FR2853910A1 (fr) 2004-10-22
WO2004094661A3 (fr) 2005-10-13

Similar Documents

Publication Publication Date Title
CY2022001I2 (el) Παραγωγα του uk-2a
CY2016035I1 (el) Θεραπευτικη χρηση αντισωματων anti-cs1
CY2015015I1 (el) Παραγωγη τιακουμυκινης
DE602004000740D1 (de) Herstellung von Nuten
FI20030967A (fi) Yhteysasetusten valinta
FI20030326A0 (fi) Datan syöttö
NO20055219D0 (no) Nye forbindelser
DE602004030750D1 (de) Lautsprecher
JP2006502186A5 (ja) β-グルカンの使用
DE602004015185D1 (de) Lautsprecher
DE602004003111D1 (de) Tiefen-basiertes Antialiasing
NO20043595L (no) Nye kortikosteroider
FI20035250A0 (fi) Fonttien skaalauksen järjestäminen
DK1597171T3 (da) Terapeutisk mikroskum
NO20054406D0 (no) Fjernbar del av merkelapp
ATE478878T1 (de) Silylierte carboxamide
FR2853910B1 (fr) Genes du psoriasis
ATE499348T1 (de) Stabiler polymorph von bifeprunoxmesilat
ITMI20041199A1 (it) Composizioni di coloranti e loro utilizzo
FR2843451B1 (fr) Fronde du type lance-pierres
DE502004000494D1 (de) Schrittschaltwerk
SE0202308D0 (sv) Genes
FI20030822A0 (fi) Toimenpiteen suorittaminen
DE502004012380D1 (de) Bekleidungsstück
SE0303412D0 (sv) Modes of operation

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse

Effective date: 20101230